Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for secondary prevention of ischemic stroke in patients with atrial fibrillation
IRCT20130311012781N5Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke and Atrial fibrillation (AFib) comparing rivaroxaban + colchicine with Control: rivaroxaban + placebo (2 arms). Primary endpoints: Recurrent stroke, Disability burden and 1 more. Started Sep 2020; status: completed.
02
Drugs
colchicine
03
Conditions
ischemic strokeAtrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT20130311012781N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130311012781N5.